Long lasting growth hormone releasing factor derivatives

Details Long lasting growth hormone releasing factor derivatives Long lasting growth hormone releasing factor derivatives

2007-09-11

2007-09-11

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S324000

Reexamination Certificate

active

10203809

ABSTRACT:
This invention relates to growth hormone releasing factor (GRF) derivatives. In particular, this invention relates to GRF peptide derivatives having an extended in vivo half-life, for promoting the endogenous production or release of growth hormone in humans and animals.

REFERENCES:
patent: 4411890 (1983-10-01), Momany
patent: 4462941 (1984-07-01), Lee et al.
patent: 4517181 (1985-05-01), Ling et al.
patent: 4518586 (1985-05-01), Rivier et al.
patent: 4528190 (1985-07-01), Vale, Jr. et al.
patent: 4529595 (1985-07-01), Rivier et al.
patent: 4563352 (1986-01-01), Rivier et al.
patent: 4585756 (1986-04-01), Brazeau, Jr. et al.
patent: 4595676 (1986-06-01), Spiess et al.
patent: 4605643 (1986-08-01), Bohlen et al.
patent: 4610976 (1986-09-01), Bohlen et al.
patent: 4626523 (1986-12-01), Vale, Jr. et al.
patent: 4628043 (1986-12-01), Spiess et al.
patent: 4689318 (1987-08-01), Kaiser et al.
patent: 4734399 (1988-03-01), Felix et al.
patent: 4784987 (1988-11-01), Rivier et al.
patent: 4843064 (1989-06-01), Vaughan et al.
patent: 4963529 (1990-10-01), Fujioka et al.
patent: 5416073 (1995-05-01), Coy et al.
patent: 5493007 (1996-02-01), Burnier et al.
patent: 5580853 (1996-12-01), Sytkowski
patent: 5612034 (1997-03-01), Pouletty et al.
patent: 5654276 (1997-08-01), Barrett et al.
patent: 5756458 (1998-05-01), Kubiak et al.
patent: 5843440 (1998-12-01), Pouletty et al.
patent: 5846936 (1998-12-01), Felix et al.
patent: 6103233 (2000-08-01), Pouletty et al.
patent: 6184201 (2001-02-01), Summer-Smith et al.
patent: 6204054 (2001-03-01), Sutton et al.
patent: 4122210 (1993-01-01), None
patent: WO98/08872 (1998-03-01), None
patent: 0188214 (1986-07-01), None
patent: 0602290 (1994-04-01), None
patent: 89/07110 (1989-08-01), None
patent: 89/07111 (1989-08-01), None
patent: WO 91/08220 (1991-06-01), None
patent: 92/18531 (1992-11-01), None
patent: 93/04081 (1993-03-01), None
patent: 93/25217 (1993-12-01), None
patent: 95/10302 (1995-04-01), None
patent: 96/06626 (1996-03-01), None
patent: 97/24445 (1997-07-01), None
patent: 98/08872 (1998-03-01), None
patent: 99/24075 (1999-05-01), None
patent: 99/24462 (1999-05-01), None
patent: 99/48536 (1999-09-01), None
patent: 00/69900 (2000-11-01), None
patent: 00/69911 (2000-11-01), None
patent: 00/76550 (2000-12-01), None
patent: 00/76551 (2000-12-01), None
patent: 01/68142 (2001-09-01), None
patent: WO 2005/099768 (2005-10-01), None
Proceedings of the 8thAmerican Peptide Symposium, 1983, 409-412.
Biotech Report, 1994/1995, 106-107.
Int. J. Biochem. Cell. Biol., 1998, 30, 1281-1284.
Endocrinology, 1982, 110 (3), 1049-1051.
J. Biol. Chem., 1995, 270 (43), 25344-25347.
J. Dev. Physiol., 1989, 12, 55-62.
Anti-Cancer Drugs, 1997, 8, 677-685.
Biopolymers (Peptide Science), 1998, 47, 451-463.
Ann. Rev. Neurosci., 1984, 7, 223-255.
Chem. Pharm. Bull., 1979, 27 (8), 1942-1944.
Proc. Natl. Acad. Sci., 1986, 83, 265-269.
TINS, 1993, 16, 403-409.
Biochem. and Biophysical Research Communications, 1984, 119 (1), 265-272.
American Journal of Physiology, Endocrinology and Metabolism, 2000, 278(1), E134-E139.
Nature Biotechnology, Nature Publishing, 1997, 15(7), 673-677.
Regulatory Peptides, 2000, 90(1-3), 27-32.
Trends in Endocrinology and Metabolism, 2000, 11(10), 401-405.
Endocrinology, 2001, 142(2), 521-527.
Kubiak, T. et al., Journal of Medicinal Chemistry, 1993, 36 (7), 888-897.
Campbell, R.M. et al., Journal of Peptide Research, 1997, 49 (6), 527-537.
Paige et al. “Prolonged circulation of recombinant human granulocyte-colony stimulating factor by covalent linkage to albumin through a heterobifunctional polyethylene glycol.” Pharm Res. Dec. 1995; 12(12):1883-8.
Poznansky et al. “Growth hormone-albumin conjugates. Reduced renal toxicity and altered plasma clearance.” FEBS Lett. Oct. 24, 1988;239(1):18-22.
International Search Report for International Application No. PCT/CA02/00123.

Affiliated with

Also associated with

Rating

Long lasting growth hormone releasing factor derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Long lasting growth hormone releasing factor derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long lasting growth hormone releasing factor derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3789506